Pain Therapeutics - Reviewing current opportunities in the effective and safe management of pain

SMi’s 15th annual Pain Therapeutics conference will be taking place on the 18th - 19th May 2015 in London, UK. Book by 27th February to save £300
 
 
Pain Therapeutics
Pain Therapeutics
LONDON - Feb. 27, 2015 - PRLog -- We are delighted to announce that Mark T Brown, MD, Executive Director, Tanezumab Clinical Program Leader for Osteoarthritis and Cancer Pain Studies, from Pfizer has joined our expert panel on day two, his presentation is entitled: Update on Tanezumab, a monoclonal antibody inhibitor of nerve growth factor, looking at the following areas: rationale for NGF inhibition in treatment of chronic pain, review of tanezumab efficacy in completed chronic pain studies and update on current status of tanezumab development

SMi’s Pain Therapeutics conference is a must attend event for attendees who want to benchmark their organisation with recent developments in the pain therapeutics arena and methods on how to overcome the challenges faced. The conference will examine principles and illustrative case studies on current activities and trends in clinical and pre-clinical evidence-based and best-practice-based pain medicine.

Benefits of Attending Include:

• New for 2015 - Presentations on personalized medicine for pain, biomarkers and CGRP receptor antagonists for migraine treatment
• Learn about Grunenthal’s latest screening approach for neuropathic pain and pain models
• Hear timely case studies from Merck and Afferent Pharmaceuticals
• Spotlight sessions - Latest updates on developments in targeting nerve growth factors
• Discover latest advances in the treatment of pain from leading, pharma, biotech and academic experts from the industry
• Interactive panel discussion the reviewing validity of animal models for chronic pain

Pain Therapeutics is sponsored by: CHDR & PRA Health Sciences

For more information or to register visit http://www.smi-online.co.uk/2015pain-therapeutics19.asp

Alternatively, contact Magdalena Georgieva on +44 (0)20 7827 6148 or email mgeorgieva@smi-online.co.uk

--------------- END ---------------

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Media Contact
Margaret Mugema
mmugema@smi-online.co.uk
+442078276072
End
Source: » Follow
Email:***@smi-online.co.uk Email Verified
Tags:Pain, Therapeutics, Medical, Health, Pharmaceutical
Industry:Event, Medical
Location:London - England - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share